Similar articles for PMID: 9274893

Year	Number of Results
1976	1
1980	1
1981	1
1983	1
1984	1
1985	2
1986	2
1987	4
1988	10
1989	2
1990	6
1991	9
1992	12
1993	11
1994	10
1995	9
1996	11
1997	13
1998	7
1999	9
2000	6
2001	11
2002	8
2003	4
2004	8
2005	5
2006	3
2007	5
2008	5
2009	7
2010	8
2011	15
2012	13
2013	6
2014	6
2015	15
2016	9
2017	14
2018	24
2019	28
2020	26
2021	35
2022	16
2023	13
2024	1

1

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, Rubin RH. George MJ, et al. Am J Med. 1997 Aug;103(2):106-13. doi: 10.1016/s0002-9343(97)80021-6. Am J Med. 1997. PMID: 9274893

2

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.

Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, Hammer S, O'Rourke E, Grady GF, Fawaz K, Kaplan MM, Hoffman MA, Katz AT, Doran M; Boston Center for Liver Transplantation CMVIG Study Group. Snydman DR, et al. Ann Intern Med. 1993 Nov 15;119(10):984-91. doi: 10.7326/0003-4819-119-10-199311150-00004. Ann Intern Med. 1993. PMID: 8214995 Clinical Trial.

3

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group.

Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG. Falagas ME, et al. Ann Intern Med. 1997 Feb 15;126(4):275-9. doi: 10.7326/0003-4819-126-4-199702150-00003. Ann Intern Med. 1997. PMID: 9036799 Clinical Trial.

4

Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.

Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, Freeman R, Rohrer R. Falagas ME, et al. Clin Transplant. 1997 Oct;11(5 Pt 1):432-7. Clin Transplant. 1997. PMID: 9361936 Clinical Trial.

5

Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

Falagas ME, Snydman DR, Griffith J, Werner BG. Falagas ME, et al. Clin Infect Dis. 1996 Sep;23(3):468-74. doi: 10.1093/clinids/23.3.468. Clin Infect Dis. 1996. PMID: 8879766

6

Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

Falagas ME, Snydman DR, George MJ, Werner B, Ruthazer R, Griffith J, Rohrer RH, Freeman R. Falagas ME, et al. Transplantation. 1996 Jun 27;61(12):1716-20. doi: 10.1097/00007890-199606270-00009. Transplantation. 1996. PMID: 8685949 Clinical Trial.

7

Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.

Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG. Falagas ME, et al. Clin Infect Dis. 1996 Aug;23(2):292-7. doi: 10.1093/clinids/23.2.292. Clin Infect Dis. 1996. PMID: 8842266

8

Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.

Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A. Wadhawan M, et al. Liver Transpl. 2012 Dec;18(12):1448-55. doi: 10.1002/lt.23540. Liver Transpl. 2012. PMID: 22903934 Free article.

9

Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.

Bodro M, Sabé N, Lladó L, Baliellas C, Niubó J, Castellote J, Fabregat J, Rafecas A, Carratalà J. Bodro M, et al. Liver Transpl. 2012 Sep;18(9):1093-9. doi: 10.1002/lt.23460. Liver Transpl. 2012. PMID: 22532316 Free article.

10

Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.

Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Hadley S, et al. Transplantation. 1995 Mar 27;59(6):851-9. Transplantation. 1995. PMID: 7535482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

386 results

Results by year